pH Pharma, New Drug for Normal-Pressure Glaucoma “Result of Clinical Phase 2b”

Result of clinical phase 2b of PHP-201, new drug candidate for glaucoma treatment, announced in 2019 APAO in Bangkok

(For more information, please refer to the link below)

http://www.biospectator.com/view/news_view.php?varAtcId=7329